Micronutrients as immunomodulatory tools for COVID-19 management.

COVID-19 rapidly turned to a global pandemic posing lethal threats to overwhelming health care capabilities, despite its relatively low mortality rate. The clinical respiratory symptoms include dry cough, fever, anosmia, breathing difficulties, and subsequent respiratory failure. No known cure is available for COVID-19. Apart from the anti-viral strategy, the supports of immune effectors and modulation of immunosuppressive mechanisms is the rationale immunomodulation approach in COVID-19 management. Diet and nutrition are essential for healthy immunity. However, a group of micronutrients plays a dominant role in immunomodulation. The deficiency of most nutrients increases the individual susceptibility to virus infection with a tendency for severe clinical presentation. Despite a shred of evidence, the supplementation of a single nutrient is not promising in the general population. Individuals at high-risk for specific nutrient deficiencies likely benefit from supplementation. The individual dietary and nutritional status assessments are critical for determining the comprehensive actions in COVID-19.

Manejo nutricional en un paciente con insuficiencia respiratoria crónica con oxigenoterapia / Nutritional management in a patient with chronic respiratory failure and oxigen therapy

Paciente masculino, 66 años de edad. Hace 7 meses hace 7 meses diagnosticado con linfoma B difuso células grandes EC IV; días antes del ingreso al hospital presenta dificultad deglutir alimentos sólidos; no presenta nauseas ni vómitos; 3 días antes del ingreso al hospital presenta dificultad para deglutir líquidos. Esta dificultad para deglutir es acompañada por la dificultad para respirar, motivo por el cual es llevado a emergencia. Sala: Medicina 7° B; fecha de nacimiento; 25 de julio de 1946; edad: 66 años; sexo, masculino; fecha de ingreso al hospital: 02/11/2012; fecha de ingreso a servicio: 03/11/2012; diagnóstico médico: insuficiencia respiratoria crónica con oxigenoterapia, linfoma B celular difuso EC IV.

Male patient, 66 years old. Patient was diagnosed with diffuse large cell lymphoma B EC IV; Five days before his admission into the hospital, patient had some difficulties in swallowing solid food; patients not present nausea or vomiting. There days before his admission into the hospital, patient presented difficulties in swallowing liquids accompanied by shortness of breath, because of that, patient is taken to hospital emergency wasd.Room: Surgery 7th; date of birth: 25 July, 1946; Age: 66 years; Gender: male; hospital admission date: 02/11/2012; Service admission date: 03/11/2012; medical diagnosis: chronic respiratory failure, nutritional management.